|
Volumn 32, Issue 8, 2009, Pages
|
Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDIABETIC AGENT;
GLIBENCLAMIDE;
HEMOGLOBIN A1C;
CARDIOVASCULAR RISK;
COGNITION;
COGNITIVE DEFECT;
CONTROLLED STUDY;
DIABETES MELLITUS;
DISEASE ASSOCIATION;
GLUCOSE BLOOD LEVEL;
GLYCEMIC CONTROL;
HUMAN;
HYPERGLYCEMIA;
INSULIN RESISTANCE;
LETTER;
MEMORY;
MINI MENTAL STATE EXAMINATION;
NON INSULIN DEPENDENT DIABETES MELLITUS;
STATISTICAL SIGNIFICANCE;
BLOOD GLUCOSE;
COGNITION;
CROSS-SECTIONAL STUDIES;
DIABETES MELLITUS, TYPE 2;
DIABETIC ANGIOPATHIES;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
MEMORY;
RESEARCH DESIGN;
RISK FACTORS;
|
EID: 68149129704
PISSN: 01495992
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc09-0658 Document Type: Letter |
Times cited : (7)
|
References (5)
|